Press release | Official website vaccine against COVID-19 Sputnik V.

Main
Newsroom
Press Releases

Press Releases

Single-dose Sputnik Light vaccine registered in Kyrgyzstan

Press release, 25.06.2021

Single-dose Sputnik Light vaccine registered in Mongolia

Press release, 11.06.2021

Sputnik V demonstrates high 94.3% efficacy and high safety profile during the vaccination campaign in Bahrain

Press release, 09.06.2021

Single-dose Sputnik Light vaccine approved for use in the Republic of the Congo

Press release, 07.06.2021

Brazil becomes the 67th country in the world to authorize Sputnik V vaccine

Press release, 05.06.2021

RDIF, Mumtalakat and Binnopharm Group to establish production of the Russian Sputnik V coronavirus vaccine in Bahrain

Press release, 03.06.2021

Sputnik Light vaccine (the first component of Sputnik V vaccine) demonstrates 78.6-83.7% efficacy among the elderly in Argentina

Press release, 02.06.2021

Single-dose Sputnik Light vaccine approved for use in Mauritius

Press release, 02.06.2021

Single-dose Sputnik Light vaccine approved for use in Palestine

Press release, 31.05.2021

Sputnik V demonstrates highest safety profile during the vaccination campaign in Serbia

Press release, 28.05.2021

3 4 5 6 7